6.84k followers • 11 symbols Watchlist by The Motley Fool
Companies that not only tend to beat the market, but pay you as they do.
Curated by The Motley Fool
Dividend Aristocrats are the model of consistency. To be a part of the club, a company must be a member of the S&P 500 index and have increased its annual dividend payment for the last 25 years. Many associate the group with income investing and dividend growth, but Dividend Aristocrats have beaten the broader market in total returns, notching better results over one-,three-, five-, and 10-year periods. Within this group of quality companies, our analysts like 10 in particular for investors looking for steady stable income (and some growth too!).How did we choose these stocks?
Each of these stocks is not only a Dividend Aristocrat but also an active recommendation of a Motley Fool premium investing service as of 8/31/2016.Who made these selections?
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.How are these weighted?
This watchlist consists of equally weighted stocks.
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|Dividend Growth Market Leaders||+1.51%||+1.48%||+23.44%||+14.86%|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|JNJ||Johnson & Johnson||143.87||-||-||4:00 p.m. EST||10.81M||6.66M||378.74B|
|KO||The Coca-Cola Company||53.22||+0.54||+1.03%||4:00 p.m. EST||13.83M||15.00M||228.71B|
|XOM||Exxon Mobil Corporation||41.98||+2.62||+6.66%||4:04 p.m. EST||46.97M||30.54M||177.50B|
|MCD||McDonald's Corporation||219.71||+2.71||+1.25%||4:00 p.m. EST||3.47M||2.98M||163.71B|
|MDT||Medtronic plc||114.06||+3.09||+2.78%||4:00 p.m. EST||6.67M||4.73M||153.34B|
|SHW||The Sherwin-Williams Company||735.29||+1.16||+0.16%||4:00 p.m. EST||518.86k||480.67k||66.78B|
|EMR||Emerson Electric Co.||79.95||+2.14||+2.75%||4:03 p.m. EST||4.21M||2.60M||47.81B|
|CTAS||Cintas Corporation||361.96||+3.69||+1.03%||4:00 p.m. EST||392.56k||433.28k||37.87B|
|AFL||Aflac Incorporated||46.13||+1.68||+3.78%||4:00 p.m. EST||5.01M||3.99M||32.40B|
|MKC||McCormick & Company, Incorporated||186.54||+3.54||+1.93%||4:00 p.m. EST||891.71k||537.77k||24.90B|
Research Affiliates Chief Investment Officer Chris Brightman joins Yahoo Finance Live to discuss how a coronavirus vaccine will impact markets and overall economic recovery.
AstraZeneca’s (AZN) positive interim results for its COVID-19 vaccine Monday was met with some confusion as health experts and Wall Street attempted to parse the company’s “up to 90%” and “average 70%” vaccine efficacy claims.
It’s a busy day ahead on the economic calendar, with U.S stats in focus. The markets may be in a forgiving mood… The FOMC minutes will also draw interest.